Orange County NC Website
Browse       Search
Custom, strategy-specific measures may be entered in this row. <br />Process Measure Count Additional Information & Helpful Hints about this Measure <br /># of unique participants, who use opioids and/or have OUD, served <br />A unique participant may participate in multiple support programs so <br />there may be some duplication of unique participants when numbers <br />across programs, project, sites, etc., are aggregated for the strategy- <br />specific impact report. A participant may receive services across local <br />government boundaries (e.g., a person with OUD may reside in one <br />county and receive services in another county). Number of referrals do <br />not equate to number of unique participants because one individual may <br />receive multiple referrals. <br />American Indian/Alaska Native Non-Hispanic <br />Asian Non-Hispanic <br />Black Non-Hispanic <br />Native Hawaiian or Other Pacific Islander Non-Hispanic <br />White Non-Hispanic <br />Hispanic <br />Some Other Race or Multiple Races <br />Unknown <br />Sum total of unique participants served (Autocalculated) <br />Does sum total (C38) match the reported # of unique patients <br />(C28)? (Autocalculated)Yes <br />Description Count Quality Measure Percent (Autocalculated)Notes Additional Information & Helpful Hints about this Measure <br /># of unique participants, who use opioids and/or have OUD, served <br />who report they have enough sterile syringes to cover every <br />injection between SSP visits <br /># of unique participants, who use opioids and/or have OUD, served <br /># of participants trained who increased their knowledge of harm <br />reduction practices <br /># of participants trained on harm reduction (e.g., overdose <br />prevention, safer use practice, disease prevention) <br />Description Count Outcome Measure Percent (Autocalculated)Notes Additional Information & Helpful Hints about this Measure <br /># of participants engaged with SSP services at _ months <br />Notes <br />DEMOGRAPHICS: Provide the following information on race and ethnicity for the # of unique participants, who use opioids and/or have OUD, served during the 2024 fiscal <br />year (i.e., July 1, 2023-June 30, 2024). <br />STRATEGY-SPECIFIC QUALITY MEASURES <br />Of the # of unique participants, who use opioids and/or have OUD, served in the count above, how many people identified as: <br />Quality measures answer the question, “How well did you do it?”. Please quantify the quality measures relevant to your implementation of this strategy. Quality measures should reflect numbers from the 2024 fiscal year (i.e., July 1, 2023-June <br />30, 2024). <br />% of participants who report they <br />have enough sterile syringes to <br />cover every injection between SSP <br />visits <br />Incomplete <br />A unique participant may participate in multiple support programs so <br />there may be some duplication of unique participants when numbers <br />across programs, project, sites, etc., are aggregated for the strategy- <br />specific impact report. A participant may receive services across local <br />government boundaries (e.g., a person with OUD may reside in one <br />county and receive services in another county). Number of referrals do <br />not equate to number of unique participants because one individual may <br />receive multiple referrals. <br />% of participants who increase <br />their knowledge of harm reduction <br />practices <br />Incomplete <br />STRATEGY-SPECIFIC OUTCOME MEASURES (PROGRAM-LEVEL) <br />Incomplete Custom, strategy-specific measures may be entered in this row. <br />Incomplete Custom, strategy-specific measures may be entered in this row. <br />Incomplete Custom, strategy-specific measures may be entered in this row. <br />Outcome measures answer the question, “Is anyone better off?”. Outcome measures can be at the program- or population-level. Please quantify the outcome measures relevant to your implementation of this strategy. Outcome measures should <br />reflect numbers from the 2024 fiscal year (i.e., July 1, 2023-June 30, 2024). <br />% of participants with OUD <br /> <br />Recommended measure at six months. If measure for engagement is <br />taken at another increment, please describe this in the "Notes" column. <br />A unique participant may participate in multiple support programs so <br />there may be some duplication of unique participants when numbers <br /> <br /> <br /> <br /> <br /> <br /> <br />DocuSign Envelope ID: 2F87EF3C-2AE9-4196-8878-5203DF2E34DA